Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Bcr is a substrate for Transglutaminase 2 cross-linking activity.

Yi SJ, Groffen J, Heisterkamp N.

BMC Biochem. 2011 Feb 10;12:8. doi: 10.1186/1471-2091-12-8.

2.

Transglutaminase 2 regulates the GTPase-activating activity of Bcr.

Yi SJ, Groffen J, Heisterkamp N.

J Biol Chem. 2009 Dec 18;284(51):35645-51. doi: 10.1074/jbc.M109.062240.

3.

Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.

Obara Y, Yanagihata Y, Abe T, Dafik L, Ishii K, Nakahata N.

Cell Signal. 2013 Mar;25(3):589-97. doi: 10.1016/j.cellsig.2012.11.021. Epub 2012 Nov 29.

PMID:
23200849
4.

Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.

Munezane T, Hasegawa T, Suritala, Tanaka A, Okada K, Okita Y.

J Vasc Surg. 2010 Oct;52(4):967-74. doi: 10.1016/j.jvs.2010.04.049. Epub 2010 Jul 7.

5.

Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2.

Biri B, Kiss B, Király R, Schlosser G, Láng O, Kőhidai L, Fésüs L, Nyitray L.

Biochem J. 2016 Jan 1;473(1):31-42. doi: 10.1042/BJ20150843. Epub 2015 Oct 20.

PMID:
26487698
6.

Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity.

Kanchan K, Ergülen E, Király R, Simon-Vecsei Z, Fuxreiter M, Fésüs L.

Biochem J. 2013 Nov 1;455(3):261-72. doi: 10.1042/BJ20130696.

PMID:
23941696
7.

Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.

Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, Iismaa SE.

J Biol Chem. 2006 May 5;281(18):12603-9. Epub 2006 Mar 7.

8.

Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis.

Jang JH, Park JS, Lee TJ, Kwon TK.

Cancer Lett. 2010 Jan 28;287(2):224-30. doi: 10.1016/j.canlet.2009.06.013. Epub 2009 Jul 24.

PMID:
19632032
9.

Role of transglutaminase 2 in PAC1 receptor mediated protection against hypoxia-induced cell death and neurite outgrowth in differentiating N2a neuroblastoma cells.

Algarni AS, Hargreaves AJ, Dickenson JM.

Biochem Pharmacol. 2017 Mar 15;128:55-73. doi: 10.1016/j.bcp.2017.01.001. Epub 2017 Jan 5.

PMID:
28065858
10.

Abr and Bcr, two homologous Rac GTPase-activating proteins, control multiple cellular functions of murine macrophages.

Cho YJ, Cunnick JM, Yi SJ, Kaartinen V, Groffen J, Heisterkamp N.

Mol Cell Biol. 2007 Feb;27(3):899-911. Epub 2006 Nov 20.

11.

Pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) gene is suppressed by transglutaminase 2 activation.

Miura A, Kambe Y, Inoue K, Tatsukawa H, Kurihara T, Griffin M, Kojima S, Miyata A.

J Biol Chem. 2013 Nov 8;288(45):32720-30. doi: 10.1074/jbc.M113.452706. Epub 2013 Sep 17.

12.

Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.

van Strien ME, de Vries HE, Chrobok NL, Bol JG, Breve JJ, van der Pol SM, Kooij G, van Buul JD, Karpuj M, Steinman L, Wilhelmus MM, Sestito C, Drukarch B, Van Dam AM.

Brain Behav Immun. 2015 Nov;50:141-54. doi: 10.1016/j.bbi.2015.06.023. Epub 2015 Jun 29.

PMID:
26133787
13.

Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.

Stamnaes J, Iversen R, du Pré MF, Chen X, Sollid LM.

PLoS One. 2015 Aug 5;10(8):e0134922. doi: 10.1371/journal.pone.0134922. eCollection 2015.

14.

A1 adenosine receptor-induced phosphorylation and modulation of transglutaminase 2 activity in H9c2 cells: A role in cell survival.

Vyas FS, Hargreaves AJ, Bonner PL, Boocock DJ, Coveney C, Dickenson JM.

Biochem Pharmacol. 2016 May 1;107:41-58. doi: 10.1016/j.bcp.2016.03.016. Epub 2016 Mar 21.

PMID:
27005940
16.

Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1.

Tatsukawa H, Fukaya Y, Frampton G, Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J, Iismaa S, Matsuura T, Tsukamoto H, Zern MA, Graham RM, Kojima S.

Gastroenterology. 2009 May;136(5):1783-95.e10. doi: 10.1053/j.gastro.2009.01.007. Epub 2009 Jan 14.

17.

The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity.

Mishra S, Murphy LJ.

Biochem Biophys Res Commun. 2006 Jan 13;339(2):726-30. Epub 2005 Nov 28.

PMID:
16313886
18.

The 55 kDa tissue transglutaminase cross-linking active isoform TG induces cell death.

Fraij BM.

Mol Carcinog. 2015 Sep;54(9):720-9. doi: 10.1002/mc.22134. Epub 2014 Jan 24.

PMID:
24464646
19.

The role of TG2 in regulating S100A4-mediated mammary tumour cell migration.

Wang Z, Griffin M.

PLoS One. 2013;8(3):e57017. doi: 10.1371/journal.pone.0057017. Epub 2013 Mar 1.

20.

Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling.

Deasey S, Nurminsky D, Shanmugasundaram S, Lima F, Nurminskaya M.

Cell Signal. 2013 Dec;25(12):2646-51. doi: 10.1016/j.cellsig.2013.08.016. Epub 2013 Aug 29.

Supplemental Content

Support Center